These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20213894)

  • 21. [The use of lucetam for improvement of cognitive functions in chronic cerebrovascular insufficiency (clinical and encephalographic study)].
    Bugrova SG; Novikov AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):44-8. PubMed ID: 18379503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vinpotropil in the treatment of dyscirculatory encephalopathy with cognitive impairment without dementia].
    Zakharov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 1):13-6. PubMed ID: 21183916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study.
    Szakáll S; Boros I; Balkay L; Emri M; Fekete I; Kerényi L; Lehel S; Márián T; Molnár T; Varga J; Galuska L; Trón L; Bereczki D; Csiba L; Gulyás B
    J Neuroimaging; 1998 Oct; 8(4):197-204. PubMed ID: 9780850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Trial of using Cavinton in cerebrovascular disorders].
    Shtok VN; Eremeeva SV
    Klin Med (Mosk); 1982 Oct; 60(10):39-42. PubMed ID: 6757560
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of cavinton on systemic and cerebral hemodynamics of patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM; Shkrobot SI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1338-42. PubMed ID: 4072532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cavinton administration in hypertensive encephalopathy].
    Putilina MV; Grishin DV
    Ter Arkh; 2008; 80(12):73-8. PubMed ID: 19227913
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of cognitive and non-cognitive symptoms in cerebrovascular disease].
    Litvinenko IV; Naumov KM; Odinak MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):35-40. PubMed ID: 24874315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cognitive functions and treatment of their impairment in elderly patients with the vertebrobasilar issufficiensy].
    Skoromets AA; Aliev KT; Lalayan TV; Pugachova EL; Smolko DG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(4):18-24. PubMed ID: 23739435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases].
    Ishchenko MM; Shkrobot SI; Borak VT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1160-4. PubMed ID: 3673409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cavinton in the prevention of the convulsive syndrome in children after birth injury].
    Dutov AA; Gal'tvanitsa GA; Volkova VA; Sukhanova ON; Lavrishcheva TG; Petrov AP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(8):21-2. PubMed ID: 1661506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcranial Doppler assessment of cerebral blood flow: effect of cardiac transplantation.
    Massaro AR; Dutra AP; Almeida DR; Diniz RV; Malheiros SM
    Neurology; 2006 Jan; 66(1):124-6. PubMed ID: 16401862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cavinton Comforte in the correction of vascular cognitive disorders].
    Shavlovskaya OA; Lokshina AB; Grishina DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8):61-65. PubMed ID: 30251979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical trials of using Cavinton in the form of intravenous infusion in the treatment of macular degeneration].
    Gerkowicz K; Toczołowski J; Jedrzejewski D; Jankowska I; Szponar B
    Klin Oczna; 1987 Mar; 89(3):95-6. PubMed ID: 3309450
    [No Abstract]   [Full Text] [Related]  

  • 34. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667
    [No Abstract]   [Full Text] [Related]  

  • 35. [The use of vinpocetine in chronic disorders caused by cerebral hypoperfusion].
    Horváth S
    Orv Hetil; 2001 Feb; 142(8):383-9. PubMed ID: 11263076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
    Burtsev EM; Shprakh VV; Savkov VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):39-44. PubMed ID: 3364094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The safe use of cavinton forte in discirculatory encephalopathy].
    Protasov KV; Dzizinskiĭ AA; Shprakh VV; Sinkevich DA; Kuklin SG; Filatova LN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(2):55-7. PubMed ID: 16548377
    [No Abstract]   [Full Text] [Related]  

  • 38. [An effect of vinpocetine (cavinton) on endothelium function in patients with chronic cerebral ischemia].
    Vaizova OE; Vengerovskiĭ AI; Alifirova VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():46-50. PubMed ID: 18196635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of deficient cerebral circulation in selecting the treatment methods for patients with circulatory encephalopathy].
    Lushchyk UB
    Klin Khir (1962); 1993; (9-10):26-9. PubMed ID: 7908998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cavinton in the treatment of acute stroke.
    Kovács L
    Ther Hung; 1985; 33(1):50-7. PubMed ID: 3841999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.